Separate names with a comma.
atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Development of Short-Duration Psychedelics ---...
MindMed Announces Positive Topline Results from Phase 2b Trial of MM-120 in Generalized Anxiety Disorder – Trial met its primary endpoint with...
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in...
US Patent US-11801256-B2 Antidepressant-psilocybin co-treatment to assist psychotherapy...
PSYCHEDELIC MEDICINES MedNous September 2023 This article was written by Dr Daniel Karlin, Chief Medical Officer, and Robert Barrow, Chief...
Slide Deck Comparisons Presentation URLs Sept 2023 -...
$SWISF $SKUR.C Sekur Private Data Ltd. Signs Distribution Agreement with VYRE Network - Reaching over 1 million Global Streamers for Its Sekur...
$SWISF News September 05, 2023 Sekur Private Data Ltd. (OTC: SWISF) Advances as Secure Communications Become Vital Against Breaches and Hacks...
Mike The Pike Productions, Inc. (OTC: MIKP) Secures Dealmaker Brandon Milostan of Greenberg Glusker as Entertainment Counsel Published Aug 29,...
Best Seller Coming to the big Screen - Wish update. Mike the Pike Entertainment @MTPPRODS $MIKP Barbara O'Connor's WISH #3 on NYT Bestseller...
STEV - Chart is bottomed and Share Structure update with 6.7mil shares going to restricted. Bullish sign here. Not much recent news, but looks to...
MindMed Completes Enrollment of Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD)...
MindMed on Fox Business Today: https://www.foxbusiness.com/video/6333843103112
Big Update For Sekur Private Data w/ CEO Alain Ghiai [MEDIA] Toronto, Ontario and New York, New York--(Newsfile Corp. - June 14, 2023) - Sekur...
[MEDIA]
Been waiting for a PR for over a year. This is the first in a very long time. Waking up?...
MindMed Announces Enrollment Milestone in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD) – Over 50% of patients dosed across 20...
MindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy...
MindMed CEO Explains New Vision For Company - TDR Exclusive [MEDIA] Is MindMed, the pioneer in psychedelic medicine, still the leading company...
Agree :)
